Clinical Trial Update: Endorotor Resection In Refractory Barrett's Dysplasia Patients [NA]

View source ↗

Summary

The clinical trial evaluating Endorotor Resection for refractory Barrett's esophagus with dysplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus with Dysplasia

Snippet

Sponsor: Interscope, Inc. | Conditions: Barrett's Esophagus With Dysplasia | NA | Status: TERMINATED